Key Details
Price
$0.54Annual ROE
-136.32%Beta
0.04Events Calendar
Next earnings date:
Apr 01, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
Apr 01, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Mar 23, 2023Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
NEW YORK, NY / ACCESSWIRE / November 5, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ("Protagenic Therapeutics" or the "Company"), a leader in biopharmaceutical innovation, announced today that on November 4, 2024 it closed its previously announced private placement pursuant to a purchase agreement (the "Purchase Agreement") for the purchase and sale of an aggregate of 1,948,295 shares of common stock, series A common stock purchase warrants to purchase an aggregate of 1,948,295 shares of common stock, with an exercise price of $0.64 per share, which are exercisable on the trading day immediately following the Stockholder Approval Date (as defined in the Purchase Agreement) for a term of eighteen (18) months from the Stockholder Approval Date, and series B common stock purchase warrants to purchase an aggregate of 1,948,295 shares of common stock with an exercise price of $0.64 per share, which are exercisable on the trading day immediately following the Stockholder Approval Date for a term of five (5) years from the Stockholder Approval Date. The purchase price of each share of common stock and associated common stock purchase warrants was $0.64 ($0.89 in the case of insiders).
Protagenic Therapeutics, Inc. (PTIX) Q4 2023 Earnings Call Transcript
Call Scheduled for Monday, April 1st, 2024, at 4:30 pm ET NEW YORK, NY / ACCESSWIRE / March 25, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a biopharmaceutical innovator, announced that the Company plans to hold its first investor earnings call to discuss the results contained in its FY 2023 Form 10K, which it plans to file that day, and its outlook for FY 2024. The Company plans to hold its earnings call, open to the public, at 4:30 pm ET on Monday, April 1st, to discuss the results of its Q4 and FY 2023, which it plans to publish in its Form 10K to be filed with the SEC that day.
FAQ
- What is the primary business of Protagenic Therapeutics?
- What is the ticker symbol for Protagenic Therapeutics?
- Does Protagenic Therapeutics pay dividends?
- What sector is Protagenic Therapeutics in?
- What industry is Protagenic Therapeutics in?
- What country is Protagenic Therapeutics based in?
- When did Protagenic Therapeutics go public?
- Is Protagenic Therapeutics in the S&P 500?
- Is Protagenic Therapeutics in the NASDAQ 100?
- Is Protagenic Therapeutics in the Dow Jones?
- When was Protagenic Therapeutics's last earnings report?
- When does Protagenic Therapeutics report earnings?
- Should I buy Protagenic Therapeutics stock now?